Nutritional Support Indications in Gastroesophageal Cancer Patients: From Perioperative to Palliative Systemic Therapy. A Comprehensive Review of the Last Decade

por Mulazzani, Giulia E.G., Corti, Francesca, Della Valle, Serena, Di Bartolomeo, Maria
Publicado 2021

The evolving strategies for the management of patients with metastatic gastric cancer: A narrative review and expert opinion

por Cascinu, Stefano, Di Bartolomeo, Maria, Lonardi, Sara, Beretta, Giordano, Fornaro, Lorenzo, De Vita, Ferdinando
Publicado 2022

Impact of Surgical Margins on Overall Survival after Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series

por Maspero, Marianna, Sposito, Carlo, Benedetti, Antonio, Virdis, Matteo, Di Bartolomeo, Maria, Milione, Massimo, Mazzaferro, Vincenzo
Publicado 2022

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

por Di Bartolomeo, Maria, Maggi, Claudia, Ricchini, Francesca, Pietrantonio, Filippo, Iacovelli, Roberto, de Braud, Filippo, Inno, Alessandro
Publicado 2015

Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies

por Iacovelli, Roberto, Pietrantonio, Filippo, Farcomeni, Alessio, Maggi, Claudia, Palazzo, Antonella, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Publicado 2014

The Landscape of Actionable Gene Fusions in Colorectal Cancer

por Pagani, Filippo, Randon, Giovanni, Guarini, Vincenzo, Raimondi, Alessandra, Prisciandaro, Michele, Lobefaro, Riccardo, Di Bartolomeo, Maria, Sozzi, Gabriella, de Braud, Filippo, Gasparini, Patrizia, Pietrantonio, Filippo
Publicado 2019

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

por Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Publicado 2014

Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status

por Pietrantonio, Filippo, Maggi, Claudia, Di Bartolomeo, Maria, Facciorusso, Maria Grazia, Perrone, Federica, Testi, Adele, Iacovelli, Roberto, Miceli, Rosalba, Bossi, Ilaria, Leone, Giorgia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Publicado 2014

Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis

por Pusceddu, Sara, Ghidini, Michele, Torchio, Martina, Corti, Francesca, Tomasello, Gianluca, Niger, Monica, Prinzi, Natalie, Nichetti, Federico, Coinu, Andrea, Di Bartolomeo, Maria, Cabiddu, Mary, Passalacqua, Rodolfo, de Braud, Filippo, Petrelli, Fausto
Publicado 2019

The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence

por Pusceddu, Sara, Vernieri, Claudio, Prinzi, Natalie, Torchio, Martina, Coppa, Jorgelina, Antista, Maria, Niger, Monica, Milione, Massimo, Giacomelli, Luca, Corti, Francesca, Prisciandaro, Michele, Monteleone, Michela, Colombo, Elena, Di Bartolomeo, Maria, de Braud, Filppo
Publicado 2020

Role of cMET in the Development and Progression of Colorectal Cancer

por Pérez-Vargas, Juan Carlos Samamé, Biondani, Pamela, Maggi, Claudia, Gariboldi, Manuela, Gloghini, Annunziata, Inno, Alessandro, Volpi, Chiara Costanza, Gualeni, Ambra Vittoria, di Bartolomeo, Maria, de Braud, Filippo, Castano, Alessandra, Bossi, Ilaria, Pietrantonio, Filippo
Publicado 2013

Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma

por Torchio, Martina, Cattaneo, Laura, Milione, Massimo, Prinzi, Natalie, Corti, Francesca, Ungari, Marco, Anichini, Andrea, Mortarini, Roberta, Occhini, Antonio, Bertino, Giulia, Maurichi, Andrea, Coppa, Jorgelina, Di Bartolomeo, Maria, de Braud, Filippo Guglielmo, Pusceddu, Sara
Publicado 2021

Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study

por Pusceddu, Sara, Vernieri, Claudio, Di Maio, Massimo, Prinzi, Natalie, Torchio, Martina, Corti, Francesca, Coppa, Jorgelina, Buzzoni, Roberto, Di Bartolomeo, Maria, Milione, Massimo, Regnault, Benjamin, Truong Thanh, Xuan-Mai, Mazzaferro, Vincenzo, de Braud, Filippo
Publicado 2021

Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms

por Guarrera, Luca, Kurosaki, Mami, Garattini, Silvio-Ken, Gianni’, Maurizio, Fasola, Gianpiero, Rossit, Luca, Prisciandaro, Michele, Di Bartolomeo, Maria, Bolis, Marco, Rizzo, Paola, Nastasi, Claudia, Foglia, Marika, Zanetti, Adriana, Paroni, Gabriela, Terao, Mineko, Garattini, Enrico
Publicado 2023

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase

por Falvella, Felicia Stefania, Caporale, Marta, Cheli, Stefania, Martinetti, Antonia, Berenato, Rosa, Maggi, Claudia, Niger, Monica, Ricchini, Francesca, Bossi, Ilaria, Di Bartolomeo, Maria, Sottotetti, Elisa, Bernardi, Francesca Futura, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Publicado 2015

One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches

por Niger, Monica, Prisciandaro, Michele, Antista, Maria, Monica, Melissa Anna Teresa, Cattaneo, Laura, Prinzi, Natalie, Manglaviti, Sara, Nichetti, Federico, Brambilla, Marta, Torchio, Martina, Corti, Francesca, Pusceddu, Sara, Coppa, Jorgelina, Mazzaferro, Vincenzo, de Braud, Filippo, Di Bartolomeo, Maria
Publicado 2020

Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer

por Castagnoli, Lorenzo, Corso, Simona, Franceschini, Alma, Raimondi, Alessandra, Bellomo, Sara Erika, Dugo, Matteo, Morano, Federica, Prisciandaro, Michele, Brich, Silvia, Belfiore, Antonino, Vingiani, Andrea, Di Bartolomeo, Maria, Pruneri, Giancarlo, Tagliabue, Elda, Giordano, Silvia, Pietrantonio, Filippo, Pupa, Serenella M.
Publicado 2023

HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial

por Pietrantonio, Filippo, Manca, Paolo, Bellomo, Sara Erika, Corso, Simona, Raimondi, Alessandra, Berrino, Enrico, Morano, Federica, Migliore, Cristina, Niger, Monica, Castagnoli, Lorenzo, Pupa, Serenella Maria, Marchiò, Caterina, Di Bartolomeo, Maria, Restuccia, Eleonora, Lambertini, Chiara, Tabernero, Josep, Giordano, Silvia
Publicado 2023

Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study

por Fucà, Giovanni, Raimondi, Alessandra, Prisciandaro, Michele, Lonardi, Sara, Cremolini, Chiara, Ratti, Margherita, Clavarezza, Matteo, Murialdo, Roberto, Sartore-Bianchi, Andrea, Smiroldo, Valeria, Berenato, Rosa, Racca, Patrizia, Bergamo, Francesca, Corallo, Salvatore, Di Bartolomeo, Maria, de Braud, Filippo, Morano, Federica, Pietrantonio, Filippo
Publicado 2022

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

por Yoshino, Takayuki, Di Bartolomeo, Maria, Raghav, Kanwal, Masuishi, Toshiki, Loupakis, Fotios, Kawakami, Hisato, Yamaguchi, Kensei, Nishina, Tomohiro, Wainberg, Zev, Elez, Elena, Rodriguez, Javier, Fakih, Marwan, Ciardiello, Fortunato, Saxena, Kapil, Kobayashi, Kojiro, Bako, Emarjola, Okuda, Yasuyuki, Meinhardt, Gerold, Grothey, Axel, Siena, Salvatore
Publicado 2023